The Future of Antibiotics

There's a really nice study done in JAMA Jenny johnstone and colleagues published the prospect trial. They looked at using lactobacillus the same compound you were using them, and they wanted to see if that prevented VAP in the ICU. Other very nice neat things are moving away from the antibiotic space and into non traditional therapies including an emphasis on microbiome therapies for recurrent C diff. I think the space is very cool we're going to talk through the data with compound SER 109 but ferrying is also developing a product in this space.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app